Replies to post #241427 on Biotech Values

[DewDiligence]

That's the scenario I was referring to in the thread about MYOV.

[DewDiligence]

INVA acquires ETTX for $2.20/sh in cash—a_50%_premium_to ETTX’s “unaffected” closing price on 1/31/22:

https://www.businesswire.com/news/home/20220523005577/en

With a 60% equity stake, INVA was already ETTX’s majority shareholder. The nominal deal value is $113M.